Corpus Intelligence IC Memo — HIALEAH HOSPITAL 2026-04-26 08:04 UTC
IC Memo — HIALEAH HOSPITAL
Investment Committee Memorandum | FL | 340 beds | Grade C | EBITDA uplift $9.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HIALEAH HOSPITAL

CCN 100053 | MIAMI-DADE, FL | 340 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HIALEAH HOSPITAL is a 340-bed suburban community hospital in MIAMI-DADE, FL with $124.6M in net patient revenue and a 6.6% operating margin. The hospital serves a payer mix of 17.2% Medicare, 6.1% Medicaid, and 76.7% commercial.

Thesis: Platform Growth. Our ML models identify $9.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.6% to 13.9% (+736bps).

Net Revenue HCRIS$124.6M
Current EBITDA COMPUTED$8.2M
Operating Margin COMPUTED6.6%
Occupancy HCRIS23.7%
Revenue / Bed COMPUTED$366K
Net-to-Gross HCRIS9.8%
Distress Probability ML54.1%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
98
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 6.6% places it above the state median. Among 98 size-comparable peers (170-680 beds), the median margin is 5.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (170-680), prioritizing same-state peers. 98 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HIALEAH HOSPITAL (Target)FL340$124.6M6.6%
UNIVERSITY OF MIAMI HOSP & CLIFL532$2.36B0.9%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
ASCENSION SACRED HEART PENSACOFL559$1.04B-10.0%
MOUNT SINAI MEDICAL CENTER OF FL481$904.2M12.2%
TALLAHASSEE MEMORIAL HOSPITALFL483$871.6M-4.8%
SHANDS JACKSONVILLE MEDICAL CEFL481$861.4M-7.1%
MORTON PLANT HOSPITALFL561$773.1M7.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.6M+210bp18mo
Cost to Collect4.5%2.5%$2.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$80K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.6M
Cost to Collect
$2.5M
Denial Rate Reduction
$2.5M
A/R Days Reduction
$1.5M
Clean Claim Rate
$80K
Total EBITDA Uplift$9.2M
Current EBITDA$8.2M
+ RCM Uplift+$9.2M
Pro Forma EBITDA$17.3M
Current Margin6.6%
Pro Forma Margin13.9%
WC Released (1x)$4.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$12.6M$145.5M11.59x63.2%
Base (11x exit)10.0x11.0x$12.6M$164.1M13.07x67.2%
Bull Case9.0x11.0x$11.3M$198.5M17.57x77.4%
Bull (12x exit)9.0x12.0x$11.3M$219.9M19.46x81.1%
Bear Case11.0x10.0x$13.8M$95.6M6.92x47.2%
Bear (11x exit)11.0x11.0x$13.8M$109.6M7.94x51.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 23.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 98 hospitals with 170-680 beds
  • Same-state prioritization (n=99)
  • Comp margins: P25=-4.8% / P50=5.0% / P75=18.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.